Extended-spectrum β-lactamases producing Klebsiella pneumoniae isolated in two hospitals in Goiânia/Brazil: Detection, prevalence, antimicrobial susceptibility and molecular typing

Brazilian Journal of Microbiology

Volumn 39, Issue 4, 2008, Pages 608-612

  Dos Santos, Daniella Fabíola ^a   Pimenta, Fabiana Cristina ^b   Alves, Rodrigo ^a   Montalvão, Edlaine Rodrigues ^a   Dos Santos, Daniela Braz ^a   Do Carmo Filho, José Rodrigues ^a  

^a PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

lactamases; Bacterial resistance; Extended spectrum lactamases (ESBL); Klebsiella pneumoniae

Indexed keywords

BACTERIA (MICROORGANISMS); KLEBSIELLA; KLEBSIELLA PNEUMONIAE;

EID: 59349083873     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822008000400002     Document Type: Article

References (32)

1. Alp, E.; Güven M.; Yildiz, O.; Aygen, B.; Voss, A.; Doganay, M. (2004). Incidence, risk factors and mortality of nosocomial pneumonia in Intensive Care Units: a prospective study. Ann Clin. Microbiol. Antimicrobiol., 3: 17-20.
2. Al-Tawfiq, J.A. (2006). Increasing Antibiotic Resistance Among Isolates of Escherichia coli Recovered From Inpatients and Outpatients in a Saudi Arabian Hospital. Infect. Control. Hosp. Epidemiol., 27 (7): 748-53.
3. Asencio, A.; Oliver, A.; Gonzáles, D.P.; Baquero, F.; Pérez-Díaz, J.C.; Ros, P. (2000). Outbreak of a multirresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin. Infect. Dis., 30: 55-60.
4. Babic, M.; Hujer, A.M.; Bomono, R.A. (2006). What's new in antibiotic resistance? Focus on β-lactamases. Elsevier., 10: 1016-32.
5. Edwards, J.J.; Betts, M.J. (2000). Carbapenems: the pinnacle of the β-lactam antibiotics or room for improvement. J. Antimicrob. Chemother., 45: 1-4.
6. Freitas, A.L.P.; Machado, D.P.; Soares, F.S.C.; Barth, A.L. (2003). Extended-Spectrum β-lactamases in Klebsiella spp. and Escherichia coli obtained in a Brazilian teaching Hospital: detection, prevalence and molecular typing. Braz. J. Microbiol., 34: 344-8.
7. Gales, A.C. (1997). Prevalência, sensibilidade a antimicrobianos e tipagem molecular de amostras de Klebsiella pneumoniae produtoras de β-lactamase de espectro ampliado. São Paulo, Brazil, 122p. (Dissertation. Escola Paulista de Medicina. Universidade Federal de São Paulo).
8. Gales, A.C.; Bolmström, A.; Sampaio, J.; Jones, R.; Sader, H.S. (1997). Antimicrobial susceptibility of Klebsiella pneumoniae producing extended-spectrum β-lactamase (ESBL) isolated in Hospital Brazil. Braz. J. Infect. Dis., 1 (4): 196-203.
9. Gales, A.C.; Jones, R.N.; Gordon, K.A.; Sader, H.S.; Wilke, W.W.; Beach, M.L.; Pfaller, M.A.; Doern, G.V.; SENTRY Study Group (Latin America) (2000). Activity and spectrum of 22 antimicrobial agents against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). J. Antimicrob. Chemother., 45: 295-303.
10. Jones, R.N. (1996). Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am. J. Med., Katsanis, 100 (suppl.): 3S-12S.
11. Katsanis, G.P.; Spargo, J.; Ferraro, M.J.; Sutton, L.; Jacoby, G.A. (1994). Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended spectrum β-lactamases. J. Clin. Microbiol., 32: 691-6.
12. Lynch, J.P. (2001). Antimicrobial resistance. It's time to reverse the trend. Chest., 119: 371S-2S.
13. Martínez-Martínez, L.; García, I.; Ballesta, S.; Benedí, V.J.; Hernandéz-Allé, S.; Pascual, A. (1998). Energy dependent accumulation of fluoroquinolones in quinolone resistant Klebsiella pneumoniae strains. Antimicrob. Ag. Chemother., 42: 1850-2.
14. Murthy, R. (2001). Implementation of strategies to control antimicrobial resistance. Chest., 119 (2): 405S-11S.
15. National Committee for Clinical Laboratory Standards (NCCLS) (2005) - Normas de desempenho para testes de sensibilidade antimicrobiana: 15° suplemento informativo. Padrão 100-S15. Wayne PA.
16. Paterson, D.L. (2006). Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control., 34: S20-S8.
17. Patterson, J.E. (2001). Is there an effect on antimicrobial resistance? Chest., 119: 426S-30S.
18. Paterson, D.L.; Ko, W.C.; Von Gottberg, A.; Mohapatra, S.; Casellas, J.M.; Goossens, H.; Mulazimoglu, L.; Trenholme, G.; Klugman, K.P.; Bonomo, R.A.; Rice, L.B.; Wagener, M.M.; McCormack, J.G.; Yu, V.L. (2004). Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin. Infect. Dis., 39 (1): 31-7.
19. Pfaller, M.A.; Hollis, R.J.; Sader, H.S. Molecular Biology - PFGE. (1992). Analysis of chromossomal fragments. In: Isenberg HD. Clinical Microbiology Handbook. Washington, ASM Press. P.10.5. C1 - 10.C.11.
20. Rahal, J.J.; Urban, C.U.; Horn, D.; Freeman, K.; Segal-Maurer, S.; Maurer, J. (1998). Class restriction of cephalosporin use control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 14: 1233-7.
21. Rice, L.B. (1999).Successful interventions for gram-negative resistance to extendedspectrum β-lactam antibiotics. Pharmacotherapy, 19 (8): 120S-8S.
22. Rice, L.B. (2001). Evolution and clinical importance of extended spectrum β-lactamase. Chest., 119: 391S-5S.
23. Sader, H.S. (2000). Antimicrobial resistance in Brazil: comparison of results from two multicenter studies. Braz. J. Infect. Dis., 4 (2): 91-9.
24. Sader, H.S.; Gales, A.C.; Pfaller, M.A.; Mendes, R.E.; Zoccoli, C.; Barth, A. (2001). Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY antimicrobial surveillance program. Braz. J. Infect. Dis., 5 (4): 200-14.
25. Sader, H.S.; Jones, R.N.; Andrade, A.; Barocchi, S.; Biedenbach, D.J.; SENTRY Participants (Latin America) (2002). Four year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteremia from bloodstream infections in Latin America Medical Centers. Diag. Microbiol. Infect. Dis., 44 (3): 273-80.
26. Shlaes, D.M.; Gerding, D.N.; John, J.F.; Craig, W.A.; Bornstein, D.L.; Duncan, R.A. (1997). Society for healthcare epidemiology of America and Infectious Disease Society of America Joint Committee on the Prevention of Antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect. Contr. Epid., 18: 275-91.
27. Schwaber, M.J.; Raney, P.M.; Rasheed, J.K.; Biddle, J.W.; Willians, P.; MCGowan Jr, J.E. (2004). Utility of NCCLS guidelines for identifying extended spectrum β-lactamase in non Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae. J. Clin. Microbiol., 42 (1): 294-8.
28. Strausbaugh, L.J.; Crossley, K.B.; Nurse, B.A.; Thrupp, L.D. (1996). Antimicrobial resistance in longterm care facilities. Infect. Control. Hosp. Epidemiol., 17: 129-40.
29. Song, W.; Moland, E.S.; Hanson, N.D.; Lewis, J.S.; Jorgensen, J.H. (2005). Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia. J. Clin. Microbiol., 43 (9): 4891-4.
30. Sousa Jr, M.A.; Ferreira, E.S.; Conceição, G.C. (2004). β-lactamases de espectro ampliado: um importante mecanismo de resistência bacteriana no laboratório clínico. Newslab. 63: 152-74.
31. Tenover, F.C.; Arbeit, R.D.; Goering, R.V.; Mickelsen, P.A.; Murray, B.E.; Persing, D.H. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33 (9): 2233-9.
32. Thomson, K.S.; Prevan, A.M.; Sanders, C.C. (1996). Novel plasmid mediated β-lactamase in Enterobacteriaceae: emerging problems for new betalactam antibiotic. Curr. Clin. Infect. Dis., 16: 151-63.